VSEL Stem Cells

Very Small Embryonic Like Stem cells (VSELs) are the cutting edge in regenerative stem cell therapy. These cells are found in everyone, but what makes these cells unique is their pluripotency. This means that they can form almost any other type of cell in your body. At Institute of Regenerative Medicine, we utilize proprietary methods of dramatically increasing their numbers in the circulating blood stream, subsequently activate them, and utilize protocols which can help them remain active. These cells have shown promise in dealing with autoimmune diseases such as Rheumatoid arthritis and Ankylosing Spondylitis, among others. VSELs are also being used in the treatment of osteoporosis, which can be considered an autoimmune disease, as well as various musculoskeletal conditions.

Since their discovery in humans in 2006, VSELs have been widely studied due to their “embryonic-like” features. They are able to replicate and multiply freely and can become any other cells in the human body. Unlike Embryonic Stem Cells, however, they do not have known cancer causing properties. Also, they are found in infants, children and adults, rather than embryos. As such, they present an ethical and potentially safer alternative to Embryonic Stem Cells.

Another interesting aspect about these cells is that they secrete Telomerase, which is the enzyme that restores the DNA telomere ends. This means that these cells typically remain very robust. These cells are taking on increasing importance in our armamentarium of cells, and we are one of the few centers in the United States that is offering this treatment.

VSELs Therapy at IRM

After we collect blood or bone marrow samples, VSELs are separated from other cells using state-of-the-art cellular processing technology. Once isolated, the VSELs are exposed to very cold temperatures simulating hypothermia, which is known to activate VSELs. Finally, we combine the VSELs with powerful growth factors harvested from platelet cells from your blood or bone marrow sample. The active VSELs and growth factors can now be returned to your body through IV. Once in your blood-stream, the VSELs will go to work immediately, seeking out areas of inflammation and injury.